Cue Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Cue Biopharma, Inc. has filed 526 SEC EDGAR filings since 19 Jun 2015

SEC filing history

Showing 126-150 of 526 matching filings.

Per page
25
Current page
6
SCHEDULE 13G/A File 005-90232

SCHEDULE 13G/A filing

Filing date
07 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-271786

424B5

Filing date
27 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-271786

424B5

Filing date
26 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38327

DEF 14A

Filing date
10 Sep 2024
Reporting date
08 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
05 Sep 2024
Reporting date
03 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Sep 2024
Reporting date
03 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-38327

PRE 14A

Filing date
28 Aug 2024
Reporting date
08 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Jun 2024
Reporting date
05 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Jun 2024
Reporting date
05 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Jun 2024
Reporting date
05 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Jun 2024
Reporting date
05 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
07 Jun 2024
Reporting date
05 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Jun 2024
Reporting date
05 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38327

DEFA14A

Filing date
24 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38327

DEF 14A

Filing date
26 Apr 2024
Reporting date
05 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .